Keyes Jason A
SEC insider (Form 3/4/5 filer). CIK 0001678152. Chief Financial Officer at BlossomHill Therapeutics, Inc. (BLSM) and 2 other issuers. 19 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in SAN DIEGO, CA.
Companies Keyes Jason A has filed insider reports for
- BlossomHill Therapeutics, Inc. (BLSM): Officer, Chief Financial Officer
- ACTUATE THERAPEUTICS, INC. (ACTU): Director
- Equillium, Inc. (EQ): Officer, Chief Financial Officer
Keyes Jason A
CIK: 0001678152
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
PurchaseDirect700 shares at avg. $16.00$11K - Aug 6, 2026BLSM
BlossomHill Therapeutics, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
56.7K shares- - May 21, 2026ACTU
ACTUATE THERAPEUTICS, INC.
AwardDirectStock Options
15K shares- - May 22, 2025ACTU
ACTUATE THERAPEUTICS, INC.
AwardDirectStock Options
15K shares- - Feb 14, 2025EQ
Equillium, Inc.
DispositionDirectEmployee Stock Option (right to buy)
175K shares- - Feb 14, 2025EQ
Equillium, Inc.
AwardDirectEmployee Stock Option (right to buy)
100K shares- - Feb 14, 2025EQ
Equillium, Inc.
DispositionDirectEmployee Stock Option (right to buy)
100K shares- - Feb 14, 2025EQ
Equillium, Inc.
AwardDirectEmployee Stock Option (right to buy)
125K shares- - Feb 14, 2025EQ
Equillium, Inc.
DispositionDirectEmployee Stock Option (right to buy)
125K shares- - Feb 14, 2025EQ
Equillium, Inc.
AwardDirectEmployee Stock Option (right to buy)
175K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 |  BLSM BlossomHill Therapeutics, Inc. | Purchase | 700 | $16.00 | $11,200 | Direct |
| Aug 6, 2026 | BLSM BlossomHill Therapeutics, Inc. | Award Employee Stock Option (Right to Buy) | 56,746 | - | - | Direct |
| May 21, 2026 |  ACTU ACTUATE THERAPEUTICS, INC. | Award Stock Options | 15,000 | - | - | Direct |
| May 22, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | Award Stock Options | 15,000 | - | - | Direct |
| Feb 14, 2025 |  EQ Equillium, Inc. | Disposition Employee Stock Option (right to buy) | 175,000 | - | - | Direct |
| Feb 14, 2025 | EQ Equillium, Inc. | Award Employee Stock Option (right to buy) | 100,000 | - | - | Direct |
| Feb 14, 2025 | EQ Equillium, Inc. | Disposition Employee Stock Option (right to buy) | 100,000 | - | - | Direct |
| Feb 14, 2025 | EQ Equillium, Inc. | Award Employee Stock Option (right to buy) | 125,000 | - | - | Direct |
| Feb 14, 2025 | EQ Equillium, Inc. | Disposition Employee Stock Option (right to buy) | 125,000 | - | - | Direct |
| Feb 14, 2025 | EQ Equillium, Inc. | Award Employee Stock Option (right to buy) | 175,000 | - | - | Direct |
1-10 of 19 transactions